Interphex 2012 will be held at New York City’s Jacob K. Javits Center on May 1-3, 2012. Headlining this event will be a series of keynote presentations presented by leading subject matter experts.
Plan now to visit Pharmapack Europe in Paris February 15-16. For more details on the event, visit www.pharmapack.fr. Hope to see you stop by the PMP News booth!
15th February 2012
9.30: Opening Address
“From Mesopotamia to modern times, THINK DIFFERENT about INNOVATION,” Patrice Noailles, Président, Seillans Investissement, France
One lot of Calcium Gluconate Injection, USP, 10%, 100 mL Pharmacy Bulk Package, has been recalled by American Regent because the vials may contain silicone particles, the company reported in a statement posted to FDA's Web site. The lot is #1006, Expiration Date: January 2013, NDC # 0517-3900-25. No other lots or sizes are involved.
American Regent reports on FDA's Web site that the company is recalling Caffeine & Sodium Benzoate Injection, USP, 250 mg/mL, 2 mL Single Dose Vial, NDC # 0517-2502-10. The recall only affects lot #0084. No other lots of Caffeine & Sodium Benzoate Injection, USP are subject to this voluntary recall, the company reports.
SCHOTT North America Inc. appoints Linda S. Mayer to the office of president and CEO, making her the first woman to head the 2,800-employee strong North American operations of the specialty glass and materials technologies manufacturer. She succeeds former President and CEO Dr. Gerald Fine who became a director of SCHOTT Corp. and a member of the company’s North American Advisory Board in January.
At Interphex this past week in New York City, Schott Pharmaceutical Packaging detailed its expanded worldwide production capacities in Argentina, Japan, and Russia.
West Pharmaceutical Services (Lionville, PA) and Progressive Medical Inc. (St. Louis, MO) sign an exclusive two-year U.S. distributor agreement for the Vial2Bag needleless reconstitution system. Progressive Medical will market the Vial2Bag system to acute care hospitals, surgical centers, in-home health providers, and closed-door pharmacy providers.
As evidence of its continued commitment to the fight against counterfeiting and illegal diversion, NanoGuardian forges ahead with several business moves in 2010. Among some of the most prominent efforts are a global collaboration with Capsugel, the extension of NanoEncryption technology to cover single-use vial caps and pre-filled syringes, and a partnership agreement with Altegrity Risk. NanoGuardian, a division of NanoInk, delivers brand protection solutions to defend against illegal diversion and counterfeiting.